LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · IEX Real-Time Price · USD
5.50
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
5.45
-0.05 (-0.91%)
Pre-market: Jul 22, 2024, 8:05 AM EDT

LifeStance Health Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021
Market Capitalization
2,1032,9641,8573,562
Market Cap Growth
-16.01%59.61%-47.85%-
Enterprise Value
2,5563,3942,2253,571
PE Ratio
--15.92-8.62-10.36
PS Ratio
1.912.812.165.34
PB Ratio
1.472.081.222.31
P/FCF Ratio
-34.18-51.64-70.18-41.87
P/OCF Ratio
-76.18-175.5835.18378.12
EV/Sales Ratio
2.323.212.595.35
EV/EBITDA Ratio
-64.40-52.26-21.10-12.90
EV/EBIT Ratio
-16.78-18.31-10.46-10.79
EV/FCF Ratio
-40.77-59.12-84.08-41.98
Debt / Equity Ratio
0.350.360.310.10
Debt / EBITDA Ratio
-11.56-7.82-4.52-0.57
Debt / FCF Ratio
-7.32-8.85-18.00-1.85
Quick Ratio
1.091.011.191.92
Current Ratio
1.181.111.332.28
Asset Turnover
0.520.490.430.36
Interest Coverage
-7.58-8.74-10.68-8.51
Return on Equity (ROE)
-11.90%-12.70%-14.10%-24.60%
Return on Assets (ROA)
-8.10%-8.60%-10.70%-18.70%
Return on Capital (ROIC)
-8.89%-9.76%-10.53%-16.82%
Earnings Yield
-8.23%-6.28%-11.61%-9.66%
FCF Yield
-3.27%-1.94%-1.42%-2.39%
Buyback Yield / Dilution
-4.28%-3.43%-8.47%-
Total Shareholder Return
-4.28%-3.43%-8.47%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).